Cargando…
The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods
Autores principales: | Xie, Yi, Liu, Pei-Pei, Lian, Ya-Jun, Liu, Hong-Bo, Kang, Jian-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799811/ https://www.ncbi.nlm.nih.gov/pubmed/31637010 http://dx.doi.org/10.1038/s41392-019-0064-7 |
Ejemplares similares
-
Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011) -
Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response
por: Panlilio, Jennifer M., et al.
Publicado: (2016) -
Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals
por: Briscoe, Vanessa J., et al.
Publicado: (2008) -
In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning
por: Weaver, Samantha R., et al.
Publicado: (2019) -
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
por: Zimniak, Melissa, et al.
Publicado: (2021)